April 19, 2014 9:30 PM ET

Pharmaceuticals

Company Overview of Tobira Therapeutics, Inc.

Executive Profile

Antoun Nabhan J.D.

Director, BayBio
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 4 different industries.

See Board Relationships
----

Background

Mr. Antoun Nabhan, J.D. served as Vice President of Business Development of Tobira Therapeutics, Inc since April 05, 2012. Mr. Nabhan was responsible for strategic transactions and partnering activities, as well as certain operating activities. Mr. Nabhan joined Tobira from Onyx Pharmaceuticals, where he held positions of increasing responsibility in its Corporate Development and Strategy group. He played a key role in that company's acquisition of Proteolix, and subsequent ...

Corporate Headquarters

198 Route 9 North
Manalapan, New Jersey 07726

United States

Phone: 732-863-5980
Fax: --

Board Members Memberships

Former Director
Former Director
Director
Founder

Education

Unknown/Other Education
The University of Chicago
JD
Harvard Law School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tobira Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.